Scheie syndrome: Enzyme replacement therapy does not prevent progression of cervical myelopathy due to spinal cord compression

Journal of Inherited Metabolic Disease

Volumn 32, Issue SUPPL. 1, 2009, Pages 321-325

  Illsinger, S ^a   Lucke T ^a   Hartmann, H ^a   Mengel, E ^b   Muller Forell W ^c   Donnerstag, F ^a   Das, A M ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LEVO IDURONIDASE;

ADULT; ARTICLE; BRAIN; CASE REPORT; CERVICAL SPINE; DISEASE COURSE; ENZYME REPLACEMENT; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HURLER SYNDROME; PATHOLOGY; PATHOPHYSIOLOGY; SPINAL CORD COMPRESSION;

ADULT; BRAIN; CERVICAL VERTEBRAE; DISEASE PROGRESSION; ENZYME REPLACEMENT THERAPY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IDURONIDASE; MUCOPOLYSACCHARIDOSIS I; SPINAL CORD COMPRESSION;

EID: 84881016898     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-009-1265-y     Document Type: Article

References (36)

1. Boelens JJ (2006) Trends in haematopoietic cell transplantation for inborn errors of metabolism. J Inherit Metab Dis 292-3:413-420
2. Braunlin EA, Rose AG, Hopwood JJ et al. (2001) Coronary artery patency following long-term successful engraftment 14 years after bone marrow transplantation in the Hurler syndrome. Am J Cardiol 889:1075-1077 (Pubitemid 33042633)
3. Cox-Brinkman J, Boelens JJ, Wraith JE et al. (2006) Haematopoietic cell transplantation (HCT) in combination with enzyme replacement therapy (ERT) in patients with Hurler syndrome. Bone Marrow Transplant 381:17-21 (Pubitemid 43923084)
4. Dickson P, McEntee M, Vogler C et al. (2007) Intrathecal enzyme replacement therapy: successful treatment of brain disease via the cerebrospinal fluid. Mol Genet Metab 911:61-68 (Pubitemid 46550919)
5. Fahnehjelm KT, Tornquist AL, Malm G et al. (2006) Ocular findings in four children with mucopolysaccharidosis IHurler (MPS I-H) treated early with haematopoietic stem cell transplantation. Acta Ophthalmol Scand 846:781-785 (Pubitemid 44688328)
6. Field RE, Buchanan JA, Copplemans MG et al. (1994) Bonemarrow transplantation in Hurler's syndrome. effect on skeletal development. J Bone Joint Surg Br 766:975-981 (Pubitemid 24368459)
7. Grewal SS, Krivit W, Defor TE et al. (2002) Outcome of second hematopoietic cell transplantation in Hurler syndrome. Bone Marrow Transplant 296:491-496 (Pubitemid 34428717)
8. Grigull L, Beilken A, Schrappe M et al. (2005) Transplantation of allogeneic CD34-selected stem cells after fludarabinebased conditioning regimen for children with mucopolysaccharidosis 1H (M. Hurler). Bone Marrow Transplant 353:265-269 (Pubitemid 40268298)
9. Gullingsrud EO, Krivit W, Summers CG (1998) Ocular abnormalities in the mucopolysaccharidoses after bone marrow transplantation. Longer follow-up. Ophthalmology 1056:1099-1105 (Pubitemid 28268337)
10. Hobbs JR,Hugh-JonesK, Barrett AJ et al. (1981) Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet 28249:709-712 (Pubitemid 11061090)
11. Jeyakumar M, Dwek RA, Butters TD et al. (2005) Storage solutions: treating lysosomal disorders of the brain. Nat Rev Neurosci 69:713-725 (Pubitemid 44773245)
12. Kachur E, Del Maestro R (2000) Mucopolysaccharidoses and spinal cord compression: case report and review of the literature with implications of bone marrow transplantation. Neurosurgery 471:223-228; discussion 228-229
13. Kakkis ED, Muenzer J, Tiller GE et al. (2001) Enzymereplacement therapy in mucopolysaccharidosis I. N Engl J Med 3443:182-188
14. Kakkis ED, McEntee M, Vogler C et al. (2004) Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I. Mol Genet Metab 831-2:163-174 (Pubitemid 39328075)
15. Khan SA, Sehat K, Calthorpe D (2003) Cervical cord compression in an elderly patient with Hurler's syndrome: a case report. Spine (Phila Pa 1976) 2816:E313-315
16. Koc ON, Day J, Nieder M et al. (2002) Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 304:215-222 (Pubitemid 35023593)
17. Krivit W, Sung JH, Shapiro EG et al. (1995) Microglia: the effector cell for reconstitution of the central nervous system following bone marrow transplantation for lysosomal and peroxisomal storage diseases. Cell Transplant 44:385-392
18. Lücke T, Das AM, Hartmann H et al. (2007) Developmental outcome in five children with Hurler syndrome after stem cell transplantation: a pilot study. Dev Med Child Neurol 499:693-696 (Pubitemid 47316792)
19. Muller I, Kustermann-Kuhn B, Holzwarth C et al. (2006) In vitro analysis of multipotent mesenchymal stromal cells as potential cellular therapeutics in neurometabolic diseases in pediatric patients. Exp Hematol 3410:1413-1419 (Pubitemid 44374843)
20. Munoz-Rojas MV, Vieira T, Costa R et al. (2008) Intrathecal enzyme replacement therapy in a patient with mucopolysaccharidosis type I and symptomatic spinal cord compression. Am J Med Genet A 146A19:2538-2544
21. Neufeld EF, Muenzer J (2001) The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited diseases, 8th edn. McGraw-Hill, New York,3421-3452
22. Peters C, Balthazor M, Shapiro EG et al. (1996) Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood 8711:4894-4902 (Pubitemid 26162394)
23. Peters C, Shapiro EG, Anderson J et al. (1998a) Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group. Blood 917:2601-2608 (Pubitemid 28155537)
24. Peters C, Shapiro EG, Krivit W (1998b) Neuropsychological development in children with Hurler syndrome following hematopoietic stem cell transplantation. Pediatr Transplant 24:250-253
25. Scott HS, Bunge S, Gal A et al. (1995) Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implications. Hum Mutat 64:288-302
26. Shapiro EG, Lockman LA, Balthazor M et al. (1995) Neuropsychological outcomes of several storage diseases with and without bone marrow transplantation. J Inherit Metab Dis 184:413-429
27. Shull RM, Kakkis ED, McEntee MF et al. (1994) Enzyme replacement in a canine model of Hurler syndrome. Proc Natl Acad Sci U S A 9126:12937-12941
28. Souillet G, Guffon N, Maire I et al. (2003) Outcome of 27 patients with Hurler 's syndrome transplanted from either related or unrelated haematopoietic stem cell sources. Bone Marrow Transplant 3112:1105-1117 (Pubitemid 36857368)
29. Tandon V, Williamson JB, Cowie RA et al. (1996) Spinal problems in mucopolysaccharidosis I (Hurler syndrome). J Bone Joint Surg Br 786:938-944 (Pubitemid 26392125)
30. Tolar J, Grewal SS, Bjoraker KJ et al. (2008) Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome. Bone Marrow Transplant 416:531-535 (Pubitemid 351472144)
31. Tzetzi D, Hamilton R, Robinson PH et al. (2007) Negative ERGs in mucopolysaccharidoses (MPS) Hurler-Scheie (I-H/S) and Hurler (I-H)-syndromes. Doc Ophthalmol 1143:153-158 (Pubitemid 46681697)
32. Weisstein JS, Delgado E, Steinbach LS et al. (2004) Musculoskeletal manifestations of Hurler syndrome: long-term follow-up after bone marrow transplantation. J Pediatr Orthop 241:97-101 (Pubitemid 38030056)
33. Wraith JE (2005) The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I. Expert Opin Pharmacother 63:489-506
34. Wraith JE, Clarke LA, Beck M et al. (2004) Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase). J Pediatr 1445:581-588 (Pubitemid 38594757)
35. Wraith JE, Beck M, Lane R et al. (2007) Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase). Pediatrics 1201:e37-46 (Pubitemid 47036214)
36. Yogalingam G, Guo XH, Muller VJ et al. (2004) Identification and molecular characterization of alpha-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy. Hum Mutat 243:199-207 (Pubitemid 39095596)